Intrinsic Value of S&P & Nasdaq Contact Us

Eli Lilly and Company LLY NYSE

NYSE • Healthcare • Drug Manufacturers - General • US • USD

SharesGrow Score
86/100
5/7 Pass
SharesGrow Intrinsic Value
$919.68
-0.3%
Analyst Price Target
$1,243.95
+34.8%

Stock Statistics — LLY

Eli Lilly and Company (LLY) has a market capitalization of $871.6B and trades at $922.50. The 52-week range is 623.78-1133.95.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of 40.1, Earnings Per Share (EPS) of $23.00, annual revenue of $65.18B.

The stock has a beta of 0.50, a last dividend of $6.2300, operates in the Healthcare sector.

Trading Data
Current Price$922.50
52-Week Range623.78-1133.95
Volume2.17M
Avg Volume (30D)3.16M
Market Cap$871.6B
Beta (1Y)0.50
Last Dividend$6.2300
Company
IPO Date1972-06-01
Employees47,000
CEODavid A. Ricks
CountryUS
ExchangeNYSE
CurrencyUSD
ISINUS5324571083
CUSIP532457108
Income (Latest Year)
Revenue$65.18B
Gross Profit$54.62B
EBITDA$27.94B
Operating Income$29.7B
Net Income$20.64B
EPS$23.00
EPS Diluted$22.95
Shares Outstanding$898M
Balance Sheet (Latest Year)
Total Assets$112.48B
Current Assets$55.63B
Cash & ST Investments$7.27B
Total Liabilities$85.94B
Total Debt$42.5B
Net Debt$35.34B
Total Equity$26.54B
Debt / Equity1.60
Valuation Ratios
P/E Ratio40.1
P/S Ratio13.37
P/B Ratio32.85
EV/EBITDA (approx)31.2
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message